scispace - formally typeset
M

Miyuki Yano

Researcher at Kumamoto University

Publications -  11
Citations -  1310

Miyuki Yano is an academic researcher from Kumamoto University. The author has contributed to research in topics: Macrophage proliferation & MAPK/ERK pathway. The author has an hindex of 10, co-authored 11 publications receiving 1247 citations. Previous affiliations of Miyuki Yano include University of Tokyo.

Papers
More filters
Journal ArticleDOI

Activation of AMP-Activated Protein Kinase Reduces Hyperglycemia-Induced Mitochondrial Reactive Oxygen Species Production and Promotes Mitochondrial Biogenesis in Human Umbilical Vein Endothelial Cells

TL;DR: Results suggest that metformin normalizes hyperglycemia-induced mtROS production by induction of MnSOD and promotion of mitochondrial biogenesis through the activation of AMPK-PGC-1alpha pathway.
Journal ArticleDOI

Adenosine Monophosphate-Activated Protein Kinase Suppresses Vascular Smooth Muscle Cell Proliferation Through the Inhibition of Cell Cycle Progression

TL;DR: The data suggest for the first time that AMPK suppresses VSMC proliferation via cell cycle regulation by p53 upregulation and AMPK activation in VSMCs may be a therapoietic target for the prevention of vascular diseases.
Journal ArticleDOI

Statins Activate Peroxisome Proliferator-Activated Receptor γ Through Extracellular Signal-Regulated Kinase 1/2 and p38 Mitogen-Activated Protein Kinase-Dependent Cyclooxygenase-2 Expression in Macrophages

TL;DR: It is demonstrated that statins inhibited lipopolysaccharide-induced tumor necrosis factor α or monocyte chemoattractant protein-1 mRNA expression, and these effects by statins were abrogated by the PPARγ antagonist T0070907 or by small interfering RNA of PPARβ or PPARα.
Journal ArticleDOI

Impact of mitochondrial reactive oxygen species and apoptosis signal-regulating kinase 1 on insulin signaling.

TL;DR: The results suggest that TNF-α increases mitochondrial ROS and activates ASK1 in Huh7 cells and that these T NF-α–induced phenomena contribute, at least in part, to impaired insulin signaling.